How can we reduce the burden of cancer?
Implementing the research agenda of the National Cancer Institute’s Cancer Epidemiology and Genetics Program
Challenge
Scientists at the National Cancer Institute’s (NCI’s) Division of Cancer Epidemiology and Genetics (DCEG) work to understand genetic and environmental determinants of cancer. They study many different types of cancer, employ a wide range of study designs and collect a broad array of epidemiologic and clinical data, as well as biological and environmental samples.
These complex, multidisciplinary studies need considerable infrastructure and resources for successful conduct, such as clinical staff and experts in the collection and handling of biological and environmental samples. For many of DCEG’s longitudinal cohort studies, expertise is needed in long-term followup methods and linking cohorts to disease and death registries. Most studies require acquiring, editing, merging, and harmonizing data from multiple sources sometimes collected over the course of many years; maintaining the data in secure databases; and preparing analytic datasets.
Solution
For more than 40 years, Westat has provided research support services to DCEG investigators. We currently hold 4 task order contracts supporting 5 branches within the Division.
Our large and highly skilled workforce has advanced, specialized capabilities in
- Multimode data collection from individuals and healthcare delivery sources
- Clinical data collection
- Biological and environmental sample collection and management
- Exposure assessment
- Geospatial analysis
- Data linkages
- Management of complex biomedical data from multiple sources
We successfully manage multiple studies conducted concurrently and respond quickly to address newly emerging scientific questions. Many of the studies we support are international, and we have effectively negotiated subcontracts and monitored research activities on every continent, including in low- and middle-income countries.
Results
Westat is proud to support research that has made major contributions to our understanding of the causes, progression, prevention, and detection of cancer. Examples include studies that have identified genetic mutations associated with cancer in high-risk individuals, studies to understand the associations of infections with cancer and progression from precancerous lesions, and studies to understand the interrelationships between environmental and genetic factors in cancer.
- 
                                Expert Interview Safeguarding Data Privacy: Innovations at WestatOctober 2025 Protecting the privacy of people who respond to surveys and censuses is a critical responsibility in federal data collection. During the 2010 Decennial Census, the… 
- 
                                Expert Interview Novel Strategies Transform Clinical Trials Into Future OpportunitiesOctober 2025 For the rigorous evaluation of novel medicines, clinical trials are essential to ensure safety and efficacy. However, clinical trials are experiencing turbulent times due to… 
- 
                                Expert Interview Real-World Insights: Nirsevimab’s Protection Against RSV in InfantsSeptember 2025 Each year in the U.S., respiratory syncytial virus, commonly known as RSV, leads to approximately 58,000 to 80,000 hospitalizations among children under age 5. The…